Article
Envision Pharma Group
AI in Medical Affairs
Summary
In this episode, Tom Caravela and Patrina Pellett discuss insights from a recent AI in Medical Affairs conference. Tom highlights the lively atmosphere and key AI topics like efficiencies, patient outcomes, and use cases. The conversation covers AI's role in content development, training, predictive analytics, and its impact on medical affairs and the patient journey. They explore AI's potential in rare disease identification and insights analysis, emphasizing the human element and business efficiencies. Key takeaways include the importance of prompt engineering and custom GPTs.
AI in Medical Affairs, patient outcomes, predictive analytics, rare disease identification, prompt engineering
Related Topics
You May Also Like
Envision Pharma Group
Podcast
MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Podcast
MSL Talk: Tom Caravela, Patrina Pellett
Fierce Pharma Engage 2025 - RECAP
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS